Vascular uptake on 18F-FDG PET/CT predicts relapse in new-onset PMR

Ningqi Dai1, Xinyi Sun2, Linzi Meng1

  • 1Department of Rheumatology and Immunology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

PubMed
Abstract

Insights

Vascular involvement in polymyalgia rheumatica (PMR) patients, detected by 18F-FDG PET/CT, predicts disease relapse and identifies subclinical giant cell arteritis (GCA). This imaging tool aids in prognosis and relapse prevention strategies.

Area of Science:

  • Rheumatology
  • Nuclear Medicine
  • Vascular Imaging

Background:

  • Polymyalgia rheumatica (PMR) can be associated with subclinical giant cell arteritis (GCA).
  • Identifying patients at high risk for PMR relapse is crucial for effective management.
  • 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is a valuable imaging modality for assessing vascular inflammation.

Purpose of the Study:

  • To evaluate the utility of 18F-FDG PET/CT in detecting vascular involvement in PMR patients.
  • To determine if vascular involvement is associated with subclinical GCA and disease relapse in PMR.
  • To identify predictors of relapse in PMR patients.

Main Methods:

  • Retrospective cohort study of 80 PMR patients undergoing 18F-FDG PET/CT.
  • Patients categorized into groups based on vascular involvement detected by PET/CT.
  • Comparison of clinical characteristics, treatments, and relapse rates; multivariate Cox regression analysis for relapse predictors.

Main Results:

  • 17.5% of PMR patients showed vascular involvement, with 93% of these having extracranial vessel involvement, suggestive of subclinical GCA.
  • Relapse rates were significantly higher in patients with subclinical GCA (71%) versus isolated PMR (29%).
  • Vascular involvement (HR 3.731) strongly predicted relapse, while arthralgia showed a protective effect (HR 0.325).

Conclusions:

  • Vascular involvement detected by 18F-FDG PET/CT is a critical predictor of relapse in PMR.
  • 18F-FDG PET/CT is useful for identifying subclinical GCA and predicting prognosis in PMR patients.
  • Further research is warranted to develop screening protocols and optimize relapse prevention strategies.